Eli Lilly is handing China sales rights for a breast cancer drug to Innovent Biologics
Innovent will take over importing, marketing, and distributing Verzenios in mainland China as generic competition looms
Overview
Innovent will take over importing, marketing, and distributing Verzenios in mainland China as generic competition looms
Source
Originally published at qz.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.
